P717: BOSUTINIB IN NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA: GASTROINTESTINAL, LIVER, EFFUSION AND RENAL SAFETY CHARACTERIZATION IN THE BFORE TRIAL

P717: BOSUTINIB IN NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA: GASTROINTESTINAL, LIVER, EFFUSION AND RENAL SAFETY CHARACTERIZATION IN THE BFORE TRIAL

Bibliographic Details
Main Authors:	J. E. Cortes, D. Milojkovic, C. Gambacorti-Passerini, V. García-Gutiérrez, M. J. Mauro, E. Leip, S. Purcell, A. Viqueira, T. H. Brümmendorf
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000845752.32594.93

Similar Items

P719: EFFICACY AND SAFETY OF BOSUTINIB IN LATER-LINE PATIENTS WITH CHRONIC MYELOID LEUKEMIA: A SUB-ANALYSIS FROM THE PHASE 4 BYOND TRIAL
by: C. Gambacorti-Passerini, et al.
Published: (2022-06-01)

PB1966: THE EFFECT OF BODY MASS INDEX ON THE SAFETY OF BOSUTINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA: A POST HOC POOLED DATA ANALYSIS
by: Susanne Isfort, et al.
Published: (2023-08-01)

Population modeling of bosutinib exposure‐response in patients with newly diagnosed chronic phase chronic myeloid leukemia
by: May Garrett, et al.
Published: (2023-09-01)

Management of adverse events associated with bosutinib treatment of chronic-phase chronic myeloid leukemia: expert panel review
by: Jorge E. Cortes, et al.
Published: (2018-12-01)

Immunological monitoring of newly diagnosed CML patients treated with bosutinib or imatinib first-line
by: Anna Kreutzman, et al.
Published: (2019-09-01)

P676: UPDATED RESULTS FROM THE TRIAL ITCC-054/COG-AAML1921: BOSUTINIB IN NEWLY DIAGNOSED AND RESISTANT/INTOLERANT PEDIATRIC PATIENTS WITH CHRONIC MYELOID LEUKEMIA
by: Erica Brivio, et al.
Published: (2023-08-01)

Correlation of plasma concentration and adverse effects of bosutinib: standard dose or dose-escalation regimens of bosutinib treatment for patients with chronic myeloid leukemia
by: Akiko Mita, et al.
Published: (2018-04-01)

An Imatinib–non‐responsive patient with an ABL Leu387Trp mutation achieves cytogenetic and molecular response under bosutinib: Case report and biological characterization
by: Ilaria Crespiatico, et al.
Published: (2020-01-01)

Bosutinib‐associated interstitial lung disease and pleural effusion: A case report and literature review
by: Qiuying (Selina) Liu, et al.
Published: (2021-05-01)

Effects of SLC22A2 808G>T polymorphism and bosutinib concentrations on serum creatinine in patients with chronic myeloid leukemia receiving bosutinib therapy
by: Maiko Abumiya, et al.
Published: (2021-03-01)

Single‐center study on SARS‐CoV‐2 infection in patients affected by CML: Vaccination status and bosutinib therapy as possible protective factors for hospitalization
by: Ivan Civettini, et al.
Published: (2023-04-01)

Bosutinib induced pleural effusions: Case report and review of tyrosine kinase inhibitors induced pulmonary toxicity
by: Natalia I. Moguillansky, MD, et al.
Published: (2017-01-01)

PB1976: SINGLE CENTER STUDY ON SARS-COV-2 INFECTION IN PATIENTS AFFECTED BY CML: VACCINATION STATUS AND BOSUTINIB THERAPY AS POSSIBLE PROTECTIVE FACTORS FOR HOSPITALIZATION.
by: Ivan Civettini, et al.
Published: (2023-08-01)

High‐grade B‐cell lymphoma developed during the treatment of chronic myeloid leukemia with bosutinib
by: Teruhito Takakuwa, et al.
Published: (2021-03-01)

Bosutinib: a SRC–ABL tyrosine kinase inhibitor for treatment of chronic myeloid leukemia
by: El Rassi F, et al.
Published: (2013-08-01)

Molecular Pathogenesis of BCR-ABL-Negative Atypical Chronic Myeloid Leukemia
by: Diletta Fontana, et al.
Published: (2021-11-01)

Bosutinib in the management of chronic myelogenous leukemia
by: Keller-von Amsberg G, et al.
Published: (2013-05-01)

Incident pulmonary arterial hypertension associated with Bosutinib
by: Shaun Yo, et al.
Published: (2020-08-01)

Newly Diagnosed Acute Myeloid Leukemia with Neck Swelling
by: Maha Al-Yahyai, et al.
Published: (2011-11-01)

Upper and lower gastrointestinal tract disorders in patients with newly diagnosed acromegaly
by: A. A. Titaeva, et al.
Published: (2016-09-01)

Newly diagnosed primary hypothyroidism applicant with massive pericardial effusion and acute renal failure
by: Ates I, et al.
Published: (2016-01-01)

Jana pulangan RM7.17b
by: Sinar Harian
Published: (2017)

Bosutinib stimulates macrophage survival, phagocytosis, and intracellular killing of bacteria
by: da Silva, Ronni A. G., et al.
Published: (2024)

Synthesis of Bosutinib from 3-Methoxy-4-hydroxybenzoic Acid
by: Xiao Jia Yin, et al.
Published: (2010-06-01)

Successful treatment with nilotinib after bosutinib-induced pulmonary arterial hypertension recurrence following dasatinib in chronic myeloid leukemia in chronic phase
by: Ibuki Takatsuka, et al.
Published: (2022-01-01)

Invasive Fungal Disease in Patients with Newly Diagnosed Acute Myeloid Leukemia
by: Anastasia I. Wasylyshyn, et al.
Published: (2021-09-01)

Cytokines profiling as prognostic markers in newly diagnosed acute myeloid leukemia
by: Hiba Shakir Ahmed, et al.
Published: (2017-01-01)

The Commemoration of the Siege of 717-18 in the Liturgical Calendar of Constantinople
by: Lauxtermann, MD
Published: (2023)

Safety, target engagement, and biomarker effects of bosutinib in dementia with Lewy bodies
by: Fernando L. Pagan, et al.
Published: (2022-01-01)

Opioid utilization among pediatric patients treated for newly diagnosed acute myeloid leukemia.
by: Kelly D Getz, et al.
Published: (2018-01-01)

A Diagnostic Conundrum in a Newly Diagnosed Ulcerative Colitis Patient Who Presented with Pleuropericardial Effusion
by: Alpaslan Tanoglu, et al.
Published: (2019-06-01)

PB1842: EARLY DEATH IN NEWLY DIAGNOSED ADULT ACUTE MYELOID LEUKEMIA
by: N. Siala, et al.
Published: (2022-06-01)

The risk of early mortality in elderly patients with newly diagnosed acute myeloid leukemia
by: Chia‐Jen Liu, et al.
Published: (2020-02-01)

FREQUENCY OF NRAS AND KRAS GENES IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA PATIENTS
by: Sidra Barlas, et al.
Published: (2020-04-01)

TP53 mutation in newly diagnosed acute myeloid leukemia and myelodysplastic syndrome
by: Pimjai Niparuck, et al.
Published: (2021-10-01)

P717: The landscape of clinical geneticists’ perspectives and practices in India
by: Sushma Patil, et al.
Published: (2024-01-01)

Inactivation of Scrapie Prions by the Electrically Charged Disinfectant CAC-717
by: Akikazu Sakudo, et al.
Published: (2020-07-01)

Romans, Egyptians, and the second Arab siege of Constantinople (717/18)
by: Booth, P
Published: (2024)

Publication Note Concerning Molecules 2002, 7, 717-720
by: Derek McPhee
Published: (2005-10-01)

Rapid LC-MS/MS Bosutinib Quantification with Applications in Metabolic Stability Estimation
by: Mohamed W. Attwa, et al.
Published: (2023-02-01)